It is of paramount importance that clinicians who manage implantable pain therapies (neuromodulation and intrathecal drug delivery systems) understand treatment risks and methods to modify those risks to improve outcomes.
4:30 Infection Prevention & Control: David A. Provenzano, MD 5:00 Anticoagulation Therapy Management for Implantable Therapies: B. Todd Sitzman, MD, MPH 5:30 Safety Guidelines for the Reduction of Severe Neurological Injury: Peter S. Staats, MD, MBA 6:00 Q&A: All
As a result of completing this course, learners will be able/ better able to:
Employ techniques to reduce the risks of surgical site infection.
Reduce the risks of neurological injury associated with implanted neurostimulation and intrathecal pumps.
Apply anticoagulation therapies to interventional pain procedures.
Narouze S, Benzon HT, Provenzano DA, Buvanendran A, De Andres J, Deer TR, Rauck R, Huntoon MA: Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the american society of regional anesthesia and pain medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Regional Anesthesia and Pain Medicine 2015; 40: 182-212
Provenzano DA, Deer T, Luginbuhl Phelps A, Drennen ZC, Thomson S, Hayek SM, Narouze S, Rana MV, Watson TW, Buvanendran A: An International Survey to Understand Infection Control Practices for Spinal Cord Stimulation. Neuromodulation 201